Amin Sharifan, PharmD

Bernabe, E.; Marcenes, W.; Abdullah; Ababneh, Hazim S.; Abate, B. J.; Abbastabar, H.; Abdel-Rahman, W. M.; Abd-Elsalam, S.; Sharifan, A.; et. al. (2026). Global and regional progress towards reduced burden of oral conditions between 2019 and 2023: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet Public Health, Volume 11, Issue 9: e630-e641

Carter, A.; Zhang, M.; Trejo, B.G.; Verma, M.; Brewer, E.D.; Lasher, D.; He, J.; Dominguez, R.-.M.V.; Movo, A.; Sharifan, A.; et. al. (2026). Global, regional, and national burden of HIV/AIDS, 1990–2023, with the estimated burden attributable to intimate partner violence and forecasted impacts of funding cuts through 2030: results from the Global Burden of Disease Study 2023. The Lancet HIV, https://doi.org/10.1016/ S2352-3018(26)00147-5: https://doi.org/10.1016/ S2352-3018(26)00147-5

Dobrescu, A.I.; Pinte, L.; Sharifan, A.; Gadinger, A.; Moser, I.; Cooper, C.; Gartlehner, G. (2026). Effectiveness, Comparative Effectiveness, and Harms of COVID-19 Vaccines in Adults Who Are Not Pregnant or Immunocompromised: A Rapid Review for the American College of Physicians. Annals of Internal Medicine, Online ahead of print: 10.7326/ANNALS-25-05044.

Flor, L. S.; Anderson, J. A.; Morgan, B. W.; Ng, M.; Bhoomadevi, A. C.; Aalruz, H.; Abaraogu, U. O.; Abd ElHafeez, S.; Sharifan, A.; et.al. (2026). Global, regional, and national prevalence of second-hand smoke and attributable disease burden in 204 countries and territories, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet Public Health, Volume 11, Issue 10: e767-e785

GBD 2021 AEMT Collaborators; Sharifan, A. (2026). Global burden of adverse effects of medical treatment from 1990 to 2021: a Global Burden of Disease Study 2021. Korean J Intern Med, 41(2): 350-366

GBD 2023 Breast Cancer Collaborators; Sharifan, A. (2026). Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet Oncology, Volume 27, Issue 3: 302-326

GBD 2023 Diarrhoeal Disease and Enteric Infectious Diseases Collaborators; Sharifan, A.; et.al (2026). Global burden of enteric infectious diseases, diarrhoeal diseases, and corresponding aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet Infectious Diseases, https://doi.org/10.1016/S1473-3099(26)00194-5.: https://doi.org/10.1016/S1473-3099(26)00194-5.

GBD 2023 Heart Failure Collaborators; Johnson, C.O.; Sharifan, A. (2026). Global, Regional, and National Burden of Heart Failure, 1990-2023. A Systematic Analysis for the Global Burden of Disease Study 2023. JAMA Cardiology, 10.1001/jamacardio.2026.4068: 10.1001/jamacardio.2026.4068

GBD 2023 IHD & Dietary Risk Factors Collaborators; Sharifan, A. (2026). Global, regional and national burden of ischemic heart disease attributable to suboptimal diet, 1990–2023: a Global Burden of Disease study. Nature Medicine, 32: 1454-1478

GBD 2023 Iran Collaborators; Sharifan, A.; et. al. (2026). Burden of 292 causes of death and life expectancy decomposition in Iran, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet Global Health, 14(5): e734-e748

GBD 2023 Maternal Mortality Collaborators; Sharifan, A. (2026). Global, regional, and national levels and trends in maternal mortality, progress towards the Sustainable Development Goals, and mortality from COVID-19 infection in pregnant women, 1990–2023: a systematic analysis for the Global Burden of Disease Study 23. Lancet Obstet Gynaecol Womens Health, 2 (5): e375-e424

GBD 2023 Meningitis & Antimicrobial Resistance Collaborators; Sharifan, A. (2026). Global, regional, and national burden of meningitis, its risk factors, and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet Neurology, 25(5): P451-468

GBD 2023 Mental Disorder Collaborators; Sharifan, A.; et. al. (2026). Updated trends in the global prevalence and burden of mental disorders, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet, 407: 2040-64

Gartlehner, G.; Banda, S.; Callaghan, M.; Chase, J.A.; Dobrescu, A.; Eisele-Metzger, A.; Flemyng, E.; Gardner, S.; Griebler, U.; Helfer, B.; Jemiolo, P.; Macura, B.; Minx J.C.; Noel-Storr, A.; Rajabzadeh Tahmasebi, N.; Sharifan, A.; Meerpohl J.J.; Thomas, J. (2026). Cochrane evaluation of (semi-)automated review methods: protocol for an adaptive platform study within reviews. Journal of Clinical Epidemiology, 198: https://doi.org/10.1016/j.jclinepi.2026.112390

Kang, J.; Kim, Hyeon J.; Park, J.; Kim, M. S.; Park, S.; Sharifan, A.; et. al. (2026). Burden of 10 mental disorders in low- and middle-income countries, 1990–2023, with forecasts to 2050: a Global Burden of Disease Study. Med, Volume 7, Issue 8: 101224

Kang, J.; et. al.; Sharifan, A. (2026). Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990–2023: a Global Burden of Disease Study. Nature Medicine, 32: 527-544

Klerings, I.; Dobrescu, A.; Nussbaumer-Streit, B.; Sharifan, A.; Neubauer-Bruckner, C.; Gartlehner, G. (2026). Evaluating search approaches for a network meta-analysis: a case study of Epistemonikos Database of Trials, CENTRAL, and other sources. BMC Medical Research Methodology, 26:145: 10.1186/s12874-026-02870-9

Knight, M.; Bienhoff, K., A, B.; Ababneh, H.S.; Abbasi, M.; Abbasi Dolatabadi, Z.; Abbasifard, M.; Abd ElHafeez, S.; Abdalla, A.N.; Sharifan, A.; et. al. (2026). Measuring the composition and availability of human resources for health by sex in 204 countries and territories, 1990–2023, and workforce gaps for universal health coverage: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet Public Health, Volume 11, Issue 9: e604-e629

Ledesma, J.R.; Zhang, M.; Liew, M.F.; Dominguez, R.-.M.V.; Whikehart, S.M.L.; Verma, M.; Ma, J.; Movo, A.; Chu, H.T.; Ostroff, S.M.; He, J.; Sharifan, A.; et. al. (2026). Global, regional, and national burden of tuberculosis and multidrug-resistant tuberculosis by HIV status, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet Infectious Diseases, 11: 1106-1130

Moser, T.K.; Dobrescu, A.I.; Sommer, I.; Goeschl, S.; Sharifan, A.; Ledinger, D.; Klerings, I.; Gartlehner, G. (2026). Efficacy, Comparative Effectiveness, and Harm of Respiratory Syncytial Virus Vaccines in Adults Who Are Not Pregnant or Immunocompromised: A Rapid Review for the American College of Physicians. Annals of Internal Medicine, Online ahead of print: 10.7326/ANNALS-25-05536.